 The EMCDDA stands for Europe in Monitoring Centre for Drugs and Drug Addiction. Our role is to contribute to healthier and safer Europe as far as drugs are concerned. We have special projects that receive a special funding from the Commission, the EU4MD project that is covering the neighboring countries of the EU. When we speak about certain partnerships, we go from Morocco to Syria and Lebanon. The partners are the key for us to collect and analyse the data in their countries and later on we are able to use their knowledge and their analysis for the more extensive and in-depth regional analysis. We develop different types of collaborations with various experts in the field of drugs from the law enforcement to collect information on the drug market and also with experts more from the health field to develop monitoring systems like for example we implemented the syringe and the wastewater analysis in Tunisia and the syringe analysis in Lebanon. It's an opportunity for us to share our knowledge with other countries. I think it gives us also an opportunity to exercise from the internal part like exercising these projects and learning more about ourselves through this experience. The lessons we have learned is that we have to increase and improve our cooperation, coordination and exchange of best practices in the region. It's only by knowing better what's going on from demand side, from supply side that we can better tackle the problems of the drugs. A collaboration that is right in this sense can help us and help us at the same time because we have to have a benefit and for our friends and our European partners and the African countries. The participation of Lebanon in this kind of investigation with the MCJJ is very important so that we can tailor our services to respond to the current situation but also to be able to inform the policies related to the drug so that it also responds to the reality of the drug use trends. It's important for the EU to finance these kind of programs because it's a mutual interest. To tackle drug problems in Europe we have to better understand what's going on in the neighbourhood and for our neighbours it's also important to know what happens in EU and how we can cooperate together and exchange information. Talking about drug use in Lebanon you cannot spare it from the economic and social crisis. We are at an increase of drug use, we are at an increase of cheap drugs, bad quality of drugs. People are at a high risk of using drugs and having more and more health problems. I hope in the future the second phase of this project will focus on the prevention and preventive measurements. We did the survey for the treatment facilities so I hope that this time we will make the survey for the preventive measurements focusing on the schools, universities, social community organisations. It's extremely important for them to understand that with the cooperation and with the support of the EU and the European Drug Agency it will help them to better understand the risks they are facing and take measures that are based as much as possible on scientific evidence.